SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

COCK CRYPTO is actively trending due to its expanding ecosystem on Cardano, marked by the recent launch of its MemeFi DApp, MemesHub.io, and its real-world asset integration through Cocky Wings LLC, a chicken wing food truck that drives token buybacks. The "Flock" community is highly engaged and bullish, emphasizing the token's unique utility, passive earning opportunities in its Arena, and strong long-term building initiatives.

Gladstone Capital Corp. is real estate investment trust, which owns net leased industrial, commercial, retail property and selectively makes long-term industrial and commercial mortgage loans. It offers debt and equity financing for growth, acquisition and recapitalization with an investment. The company was founded by David J. Gladstone on May 30, 2001 and is headquartered in McLean, VA.

Gladstone Capital Corp.

Gladstone Capital ($GLAD) is trending as analysts update their ratings and price targets, sparking community discussion around the stock's potential. Some traders are highlighting options activity and potential ROI, while others are weighing in on the BDC's dividend yield and recent risk factor updates. Overall, community members are actively discussing the company's financial health and its appeal as a dividend stock.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT Crypto is experiencing a notable surge, driven by its recent token distribution and a significant increase in trading volume, moving into price discovery. Community conversation frequently emphasizes its privacy-focused technology, strategic position within the Cardano ecosystem for institutional adoption, and robust ZK-Snarks implementation, though some express cautionary views on its rapid ascent.

Choice Hotels International, Inc. engages in the franchising and operations of hotels. It operates through the Hotel Franchising, and Corporate and Other segments. The Hotel Franchising segment refers to the hotel franchising operations consisting of the company's several hotel brands. The Corporate and Other segment deals with hotel revenues and rental income related to office buildings owned by the company. The company was founded in 1939 and is headquartered in North Bethesda, MD.

Choice Hotels International, Inc.

Choice Hotels is trending as it abandons its bid for Wyndham, a move welcomed by investors with a significant share repurchase program increase and an analyst upgrade. The focus now shifts to CHH's strategic organic growth initiatives, particularly its robust expansion in extended-stay brands and global markets, alongside its commitment to shareholder returns.

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

BeOne Medicines Ltd - ADR

BeiGene Ltd - ADR

BeiGene, recently rebranded as BeOne Medicines (ONC), is trending due to multiple positive regulatory developments, including FDA Fast Track designations for pipeline assets like BGBB2033 and BGB-16673, alongside recent approvals for its key oncology treatments such as Tevimbra and a new Brukinsa tablet formulation. Despite broader market noise and macro pressures, the community highlights the company's strong pipeline, market-leading product growth, and consistent execution against competitors, fueling analyst upgrades and ongoing speculation about potential partnerships or acquisition in the re-evaluating pharmaceutical sector.

TOSHI

TOSHI is currently trending with significant community engagement, largely due to its established utility on the Base network, offering features like token lockers and staking that set it apart. Despite recent market fluctuations, many investors view current price levels as an accumulation opportunity, maintaining a strong long-term bullish sentiment fueled by its identity as the "Face of Base" and ongoing speculation about potential major exchange listings.

Medical Properties Trust, Inc. is a self-advised real estate investment trust. It engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie in 2003 and is headquartered in Birmingham, AL.

Medical Properties Trust Inc

Medical Properties Trust is a focal point of market discussion after its dividend increase and significant share buyback authorization, fueling expectations of a turnaround following major tenant resolutions. Bullish sentiment points to extreme undervaluation and potential for a substantial short squeeze, driven by the high short interest, while skeptics continue to raise concerns about hospital profitability and debt load. This sharp divergence in outlook is keeping the stock trending amidst broader shifts in the healthcare REIT sector and interest rate expectations.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT is a focal point of discussion following its listing on a prominent retail trading platform and deep integration with the Coinbase Base ecosystem as a decentralized exchange. While many in the community highlight its significant growth potential due to its comparatively low market valuation against competitors, others voice concerns over its history of volatility and past performance. This polarized sentiment underscores intense speculation around its future trajectory.

Global X Funds - Global X Silver Miners ETF

The Global X Silver Miners ETF is trending as silver prices continue a parabolic ascent, driving community discussion around a potential short squeeze and historic structural supply deficits. While some note the ETF's lagging performance relative to the metal, many anticipate a significant catch-up rally for miners, fueled by record industrial demand from sectors like AI and EVs, with calls for triple-digit silver gaining momentum.

Avalanche is a high throughput smart contract blockchain platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is gaining significant traction following Bitwise's innovative ETF filing, which includes staking functionality and suggests growing institutional interest with potential for substantial capital inflow. The platform continues to advance in Real World Asset tokenization and expand strategically in the MENA region, fueling community discussion around its long-term utility despite some short-term price frustrations. These developments highlight AVAX's evolving role in the broader crypto ecosystem, attracting both optimistic investors and those monitoring its performance closely.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Recommendation of "Moderate Buy" by Brokerages

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, MarketBeat reports. One...

Zevra Therapeutics, Inc. $ZVRA Holdings Boosted by Stonepine Capital Management LLC

Stonepine Capital Management LLC boosted its stake in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) by 19.3% in the second quarter, according to the company in its most recent Form...

Zevra Therapeutics (NASDAQ:ZVRA) Trading Up 3.8% - Here's Why

Zevra Therapeutics (NASDAQ:ZVRA) Trading Up 3.8% - Should You Buy...

Campbell & CO Investment Adviser LLC Buys Shares of 83,245 Zevra Therapeutics, Inc. $ZVRA

Campbell & CO Investment Adviser LLC purchased a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Los Angeles Capital Management LLC Buys Shares of 121,225 Zevra Therapeutics, Inc. $ZVRA

Los Angeles Capital Management LLC purchased a new stake in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F...

Research Analysts Set Expectations for ZVRA FY2025 Earnings

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Investment analysts at William Blair lifted their FY2025 earnings estimates for Zevra Therapeutics in a research report issued to clients and...

FY2025 EPS Estimate for Zevra Therapeutics Raised by Analyst

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for Zevra Therapeutics in a note issued to...

William Blair Analysts Boost Earnings Estimates for ZVRA

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - William Blair lifted their Q3 2026 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a report issued on Wednesday, November...

FY2026 EPS Estimates for ZVRA Decreased by Cantor Fitzgerald

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2026 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on...

Zevra Therapeutics (NASDAQ:ZVRA) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen upgraded Zevra Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Current Price	$8.87
Prev Close	$8.64
Open	$8.61
Dividend Yield	0.00%
50-Day Moving Average	$9.28
Beta	0.93
Avg. Volume	1.68M
PE Ratio	14.06

52-Week High	$13.16
52-Week Low	$6.19
Market Capitalization	$499.36M
EPS (Annual)	-$2.28
Price to Book	3.74
Revenue Per Employee	$400,203.39
Enterprise Value/EBITDA	N/A

ZVRA
Zevra Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZVRA News

ZVRAZevra Therapeutics Inc